Why Castle Biosciences Stock Is Jumping Today
The genetic-testing company beat expectations with its Q2 results.
Source: fool.com
Page 3 - Castle Bioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Castle Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Castle Bioscience Today - Breaking & Trending Today
Financial Contrast: MedTech Acquisition (NASDAQ:MTAC) versus Castle Biosciences (NASDAQ:CSTL)
MedTech Acquisition (NASDAQ:MTAC – Get Free Report) and Castle Biosciences (NASDAQ:CSTL – Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, valuation, earnings, analyst recommendations, risk, institutional ownership and dividends. Analyst Ratings This is a summary of […]
Source: defenseworld.net
Castle Biosciences to Share New Data on DecisionDx®-Melanoma and DecisionDx®-UM at the 2023 ASCO Annual Meeting
Castle Biosciences, Inc. , a company improving health through innovative tests that guide patient care, today announced that new data on DecisionDx®-Melanoma and DecisionDx®-UM will be shared... | June 3, 2023
Source: marketscreener.com
Critical Comparison: Renalytix (NASDAQ:RNLX) vs. Castle Biosciences (NASDAQ:CSTL)
Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.
Source: etfdailynews.com
-$0.58 EPS Expected for Castle Biosciences, Inc. (NASDAQ:CSTL) This Quarter
Analysts forecast that Castle Biosciences, Inc. (NASDAQ:CSTL – Get Rating) will announce ($0.58) earnings per share for the current fiscal quarter, Zacks Investment Research reports. Two analysts have issued estimates for Castle Biosciences’ earnings, with the lowest EPS estimate coming in at ($0.65) and the highest estimate coming in at ($0.52). Castle Biosciences posted earnings […]
Source: etfdailynews.com